Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner
Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner have?
Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner has 5 citations in the OpenAlex counts ScholarIQ stores.
When was Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner published?
Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner has 2019 year in the ScholarIQ index.
What is the open-access status of Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner?
Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner has closed oa status in the ScholarIQ index.
What is the DOI of Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner?
The DOI for Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner is on the source record.
What is the PMID of Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner?
The PMID for Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner is on the source record.
What is the OpenAlex record for Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner?
The OpenAlex for Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner is on the source record.